Video

Patients With CRC: Advocate to Have Your Tumor Tested

Author(s):

Sarah DeBord

By getting their tumor genetically tested, a patient may find out that they are eligible for certain treatment options.

At this year's American Society of Clinical Oncology (ASCO) Annual Meeting, we spoke with Sarah DeBord, the communications and project manager at the Colon Cancer Coalition.

Treatment for colorectal cancer is becoming more personalized, so it is important that patients talk to their health care providers about having their tumor tested for genetic modifications such as microsatellite instability-high (MSI-H) status, which will likely be a deciding factor in the treatment that the patient gets.

Music: https://www.bensound.com

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content
LUT014 improved rashes in patients with colorectal cancer undergoing anti-EGFR therapy: © stock.adobe.com.
May 1st 2025

BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer

Spencer Feldman
LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
The first patient with metastatic colorectal cancer has received TCMCB07 in a phase 2 trial to prevent weight loss in those undergoing chemotherapy: © stock.adobe.com.
April 18th 2025

First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07

Spencer Feldman
The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Illustration of a smiling woman with blond hair and glasses
April 11th 2025

Spring Forward: How I Stay Grounded and Hopeful with Lynch Syndrome

Georgia Hurst
Living with Lynch isn't easy, but it's not all doom and gloom. It's a call to live deliberately.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.